PHILADELPHIA - PennZone -- ExpressCells, Inc., a biotechnology company that creates advanced cell lines for research, was awarded a silver designation on the Pepperdine Graziadio Business School's third annual Most Fundable Companies® List. ExpressCells competed against over 4,500 early-stage U.S. startups spanning all 50 states, all with less than $10 million in annual revenue, to be named among a list of twenty. The Most Fundable Companies initiative is designed to recognize exceptional entrepreneurs who are solving today's problems with inventive solutions and are also seeking investment capital to fuel their company's growth.
"Since starting ExpressCells in 2018, we've been focused on helping biological researchers conduct better experiments.. The Most Fundable Companies initiative provided us with a data-driven analysis that we have already incorporated into our fundraising activities," said Matt Handel, CEO. "It's validating that Pepperdine Graziadio Business School recognizes entrepreneurs throughout the country and provides resources to assist startups in securing private capital to accelerate meaningful innovation across industries and communities."
More on The PennZone
The Most Fundable Companies initiative involved a multi-phase assessment that evaluated several company variables, including financial projections, market opportunity, intellectual property, and the strength of the management team, all of which were used to produce a fundability score. The Most Fundable Companies were evaluated and selected based on their readiness for private investment. Most Fundable Companies is powered by The Venture Alliance.
As a winner on the Most Fundable Companies List, ExpressCells will be profiled on Entrepreneur.com and be featured in the December print issue of the magazine. For a complete list of the winners, visit www.pepperdine.edu/mfc-list, where you can vote for ExpressCells as the "crowd favorite" through November 1.
The Pepperdine Most Fundable Companies list does not represent an offer to sell securities. It neither constitutes investment advice, nor is an endorsement of any particular product or service. Pepperdine University is not a broker-dealer and does not perform services provided by a broker-dealer, including but not limited to any financial or investment advising.
More on The PennZone
About ExpressCells
ExpressCells is a private biotechnology company based in Philadelphia, PA. Its uses it proprietary genome editing technology, in combination with CRISPR/Cas9, to create advanced, knock-in cell lines to enhance drug discovery and other biological research. It shortens the time for delivery of knock-in cell lines by up to 75% relative to current technologies. The speed of the process allows ExpressCells to insert one to three genes into the same cell line. ExpressCells sells both custom cell lines—each designed to meet the specific requirements of an individual scientist—and catalog cell lines.
ExpressCells' genetic engineering technology was invented at the Temple University School of Pharmacy by Oscar Perez-Leal, MD. ExpressCells holds a global, exclusive license on this technology. For more information, visit xpresscells.com (http://www.xpresscells.com/).
"Since starting ExpressCells in 2018, we've been focused on helping biological researchers conduct better experiments.. The Most Fundable Companies initiative provided us with a data-driven analysis that we have already incorporated into our fundraising activities," said Matt Handel, CEO. "It's validating that Pepperdine Graziadio Business School recognizes entrepreneurs throughout the country and provides resources to assist startups in securing private capital to accelerate meaningful innovation across industries and communities."
More on The PennZone
- INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Evolus, Inc. (EOLS) Investors
- DEADLINE REMINDER: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Pintec Technology Holdings Limited (PT)
- All of the "Favorite Brands" - Scrubs 2020
- INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of First American Financial Corporation (FAF) on Behalf of Investors
- TVS Inspirational Network Adds Faith Based Classic TV Shows to Post Cable Network
The Most Fundable Companies initiative involved a multi-phase assessment that evaluated several company variables, including financial projections, market opportunity, intellectual property, and the strength of the management team, all of which were used to produce a fundability score. The Most Fundable Companies were evaluated and selected based on their readiness for private investment. Most Fundable Companies is powered by The Venture Alliance.
As a winner on the Most Fundable Companies List, ExpressCells will be profiled on Entrepreneur.com and be featured in the December print issue of the magazine. For a complete list of the winners, visit www.pepperdine.edu/mfc-list, where you can vote for ExpressCells as the "crowd favorite" through November 1.
The Pepperdine Most Fundable Companies list does not represent an offer to sell securities. It neither constitutes investment advice, nor is an endorsement of any particular product or service. Pepperdine University is not a broker-dealer and does not perform services provided by a broker-dealer, including but not limited to any financial or investment advising.
More on The PennZone
- Pennsylvania: Wolf Administration Encourages Participation in National Prescription Drug Take-Back Day
- Why You Need to Toss Your Scrubs & Buy New
- CEO Coaching International Congratulates Client Criterion HCM on Top Workplaces Title
- Ansys Receives Two TSMC Open Innovation Platform Partner of the Year Awards
- TomCat Films ignites the fireplace video category with 'My Fireplace Girl' series of DVDs and Streaming Videos
About ExpressCells
ExpressCells is a private biotechnology company based in Philadelphia, PA. Its uses it proprietary genome editing technology, in combination with CRISPR/Cas9, to create advanced, knock-in cell lines to enhance drug discovery and other biological research. It shortens the time for delivery of knock-in cell lines by up to 75% relative to current technologies. The speed of the process allows ExpressCells to insert one to three genes into the same cell line. ExpressCells sells both custom cell lines—each designed to meet the specific requirements of an individual scientist—and catalog cell lines.
ExpressCells' genetic engineering technology was invented at the Temple University School of Pharmacy by Oscar Perez-Leal, MD. ExpressCells holds a global, exclusive license on this technology. For more information, visit xpresscells.com (http://www.xpresscells.com/).
Source: ExpressCells
0 Comments
Latest on The PennZone
- TVS Select Network to Fill Quibi Gap With Free Mobile Program Focus on WatchYour.TV Platform
- Dental Implants in Springfield Start at Only $750
- KDG Named a Top 2020 B2B Company by Clutch.co
- Freya Systems Takes Off As One Of Philadelphia100®'s Fastest Growing Companies
- Pharmaceutical Giant Mallinckrodt Bankruptcy Threatens Lawsuit Filed by Local Unions and Delaware Valley Health Care Coalition, Worth Hundreds of Millions of Dollars
- Longstanding Viera/Suntree brokerage Vista Florida Realty LLC merges with Dale Sorensen Real Estate, Inc
- Hilco Redevelopment Partners to Invest Hundreds of Millions of Dollars to Decommission, Demolish and Remediate the Former PES Refinery Site in Southwest Philadelphia
- Lehigh Valley Orthodontist Offering Braces in Easton for Only $3,995, No Hidden Fees
- Pennsylvania: Governor Wolf Announces $181 Million Investment in Water Infrastructure Projects in 12 Counties
- Michael Meyer Hosts Virtual Event on Communication
- TVS Television Network.Com Adds Iconic Classic TV Series For Post Cable Network Service
- BeBop Sensors' Forte Data Glove Adds Haptic Interaction Support for Oculus 2 and Unreal Engine
- LYRIC names Toni Newman as New Interim Executive Director and Jodi Schwartz as President
- Pennsylvania American Water President Mike Doran Joins Pittsburgh Works Together Board of Directors
- BitRouter Announces Dihedral Software Release for its ATSC3pro Receiver at NAB Show New York
- High School Responder President and Founder Barbara A. Grimm Announces the Launch of High School Responder™ and Appoints Fintech Pioneer Edwin P. Baldry as Chairman of the Board
- Radian to Webcast Third Quarter Conference Call
- Braeden Lichti - What's Next for the Healthcare Sector?
- Scottsdale Plastic Surgeon Dr. Patti Flint now offering sought-after lip lift procedure
- Entrepreneur, Investor Signs $100,000 Contract With Hotel To Host First Female Founders Pitch Summit Despite Pandemic